Trial Profile
Evaluation of Serum Level of Golimumab and Antibodies Anti-Golimumab in Patients with Rheumatic Diseases: Results from a Local Registry
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Pharmacodynamics
- 02 Sep 2015 New trial record